ZOLL Medical Corp. (NSDQ:ZOLL) is in the army now, having received 510(K) clearance from the U.S. Food & Drug Administration for a Propaq MD Monitor/Defibrillator designed specifically for use by the military.
The announcement comes days after the Billerica, Mass.-based resuscitation products maker announced last week that its military business was down significantly in the third quarter.
Zoll reported revenues of $111.3 million in its third quarter, compared with $95 million during the same period last year, a 17 percent increase overall. However, the company’s hospital division, which includes military contracts, contracted 8 percent during the quarter based on a lack of orders from the armed forces.
Company officials were predictably bullish on news of the FDA clearance.
“The approval of this product marks a milestone for ZOLL in terms of expansion of business opportunities with military organizations around the world,” said ZOLL President Jonathan Rennert in a prepared statement.
Officials said the monitor was a joint project with the U.S. Dept. of Defense and facilitated by grants from the U.S. Army Medical Research and Development Command.